CYDX.US Cyduct Diagnostics Inc

Healthcare Health Care Equipment & Supplies USA Stocks
0.9118 USD
Close of Nov 14, 2026
0.3980 2.90
Market cap
USD 11.7M
P/E
1.2x
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is CYDX.US undervalued?

Graham number

The Graham number of Cyduct Diagnostics Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Cyduct Diagnostics Inc fundamental analysis

No fundamental analysis for Cyduct Diagnostics Inc yet.

Cyduct Diagnostics Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Cyduct Diagnostics Inc

CYduct Diagnostics, Inc., a healthcare company, develops, produces, and markets medical devices for the assessment, identification, diagnosis and treatment of breast cancer. The company offers HALO system, a noninvasive device that utilizes proprietary technology to obtain breast fluid; and MammoView, a fiberoptic technology with the ability to view and collect cells and other abnormalities. It also provides women and clinicians with technology that will lead the Intraductal…

Full company profile